Circulating biomarkers in hepatocellular carcinoma

被引：0
|
作者：
Karen L. Morris
Jonathan D. Tugwood
Leila Khoja
Matthew Lancashire
Robert Sloane
Debbie Burt
Patrick Shenjere
Cong Zhou
Clare Hodgson
Toshihiko Ohtomo
Atsuhiko Katoh
Takahiro Ishiguro
Juan W. Valle
Caroline Dive
机构：
[1] University of Manchester,Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute
[2] Chugai Pharmaceutical Co. Ltd.,Manchester Academic Health Sciences Centre
[3] The Christie NHS Foundation Trust,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 74卷
关键词：
Circulating tumour cells (CTCs); Hepatocellular carcinoma (HCC); Cytokeratin 18 (CK18); Prognostic biomarker; Glypican-3 (GPC3);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：323 / 332
页数：9
相关论文
共 50 条
  • [1] Circulating biomarkers in hepatocellular carcinoma
    Morris, Karen L.
    Tugwood, Jonathan D.
    Khoja, Leila
    Lancashire, Matthew
    Sloane, Robert
    Burt, Debbie
    Shenjere, Patrick
    Zhou, Cong
    Hodgson, Clare
    Ohtomo, Toshihiko
    Katoh, Atsuhiko
    Ishiguro, Takahiro
    Valle, Juan W.
    Dive, Caroline
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) : 323 - 332
  • [2] Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma
    Qu, Kevin Z.
    Zhang, Ke
    Li, HaiRong
    Afdhal, Nezam H.
    Albitar, Maher
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 (04) : 355 - 360
  • [3] CIRCULATING MICRORNA IN HEPATOCELLULAR CARCINOMA AS PROGNOSTIC BIOMARKERS
    Pascut, D.
    Krmac, H.
    Mezzina, N.
    Patti, R.
    Licastro, D.
    Dal Monego, S.
    Abazia, C.
    Petraccia, L.
    Masutti, F.
    Croce, S. L.
    Calligaris, R.
    Tiribelli, C.
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 : E23 - E23
  • [4] Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
    Johnson, Philip
    Zhou, Qing
    Dao, Doan Y.
    Lo, Y. M. Dennis
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (10) : 670 - 681
  • [5] Circulating biomarkers for early detection of hepatocellular carcinoma
    Beudeker, Boris J. B.
    Boonstra, Andre
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [6] Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
    Philip Johnson
    Qing Zhou
    Doan Y Dao
    Y. M. Dennis Lo
    [J]. Nature Reviews Gastroenterology & Hepatology, 2022, 19 : 670 - 681
  • [7] Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma
    Qi, J.
    Wang, J.
    Katayama, H.
    Sen, S.
    Liu, S. M.
    [J]. NEOPLASMA, 2013, 60 (02) : 135 - 142
  • [8] Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
    Yu Jin
    Ye Shen Wong
    Brian K. P. Goh
    Chung Yip Chan
    Peng Chung Cheow
    Pierce K. H. Chow
    Tony K. H. Lim
    George B. B. Goh
    Thinesh Lee Krishnamoorthy
    Rajneesh Kumar
    Tze Pin Ng
    Samuel S. Chong
    Hwee Huang Tan
    Alexander Y. F. Chung
    London Lucien P. J. Ooi
    Jason P. E. Chang
    Chee Kiat Tan
    Caroline G. L. Lee
    [J]. Scientific Reports, 9
  • [9] Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
    Jin, Yu
    Wong, Ye Shen
    Goh, Brian K. P.
    Chan, ChungYip
    Cheow, Peng Chung
    Chow, Pierce K. H.
    Lim, Tony K. H.
    Goh, George B. B.
    Krishnamoorthy, Thinesh Lee
    Kumar, Rajneesh
    Ng, Tze Pin
    Chong, Samuel S.
    Tan, Hwee Huang
    Chung, AlexanderY F.
    Ooi, London Lucien P. J.
    Chang, Jason P. E.
    Tan, Chee Kiat
    Lee, Caroline G. L.
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [10] Hepatocellular carcinoma diagnosis: Circulating microRNAs emerge as robust biomarkers
    Gougelet, Angelique
    Colnot, Sabine
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (04) : 367 - 369
12345